LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement

BACKGROUND: Lymphocyte antigen 6 complex, locus K (LY6K) is a putative oncogene in various cancers. Elevated expression of LY6K is correlated with poor patient prognosis in glioblastoma (GBM). The aim of this study is to advance our understanding of the mechanism by which LY6K contributes to GBM tum...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Sastry, Namratha G, Wan, Xuechao, Huang, Tianzhi, Alvarez, Angel A, Pangeni, Rajendra P, Song, Xiao, James, Charles David, Horbinski, Craig M, Brennan, Cameron W, Nakano, Ichiro, Hu, Bo, Cheng, Shi-Yuan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Basic and Translational Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523463/
https://ncbi.nlm.nih.gov/pubmed/32055849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa032
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak